Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Gilead Sciences

People at-risk of HIV in England could get PrEP from September

10,000 people will use Gilead’s Truvada in the upcoming trial

Bayer symbol

EMA clears Bayer’s Stivarga for liver cancer

The multikinase inhibitor will treat patients with HCC

Google: We’re not a big healthcare company… yet

Alphabet's Eric Schmidt on where his company currently sits within the life sciences landscape

Glythera appoints Dr Mike Owen

He joins as a non-executive director

- PMLiVE

European CTR implementation advances ethical assessment of clinical trials

Assessment process is being integrated into national laws

- PMLiVE

Not dying of ignorance – 30 years on

Behavioural changes with HIV and AIDS

- PMLiVE

Market dynamics, marketing and analytics

Ways to ensure that we know our market better than our competitors and use that knowledge to our advantage

Don’t sweat the small stuff

Achieving sustainable resilience

Bristol-Myers Squibb (BMS) building

BMS boosts immuno-oncology with $2.3bn IFM buy

Boston-based group will operate as a subsidiary of BMS

A man walks into a surgery: The role of storytelling in pharma marketing

Communicating through stories can make your brand messages more meaningful, memorable and persuasive

Life Healthcare Communications

- PMLiVE

Teva to cut 7000 jobs, close 15 manufacturing sites

Missed second-quarter sales expectations prompt the cutbacks

- PMLiVE

How to keep your name development on schedule after the recent EMA NRG announcement

Three key action points

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links